Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018-2021.
Humans
Uganda
/ epidemiology
Infant
HIV Infections
/ drug therapy
Point-of-Care Testing
Early Diagnosis
Female
Infant, Newborn
Male
Anti-HIV Agents
/ therapeutic use
Infectious Disease Transmission, Vertical
/ prevention & control
HIV Testing
/ statistics & numerical data
Anti-Retroviral Agents
/ therapeutic use
Antiretroviral therapy
Early infant diagnosis
HIV-exposed
Point-of-care
Uganda
Journal
AIDS research and therapy
ISSN: 1742-6405
Titre abrégé: AIDS Res Ther
Pays: England
ID NLM: 101237921
Informations de publication
Date de publication:
15 May 2024
15 May 2024
Historique:
received:
27
11
2023
accepted:
05
04
2024
medline:
16
5
2024
pubmed:
16
5
2024
entrez:
15
5
2024
Statut:
epublish
Résumé
Uganda Ministry of Health (MOH) recommends a first HIV DNA-PCR test at 4-6 weeks for early infant diagnosis (EID) of HIV-exposed infants (HEI) and immediate return of results. WHO recommends initiating antiretroviral therapy (ART) ≤ 7 days from HIV diagnosis. In 2019, MOH introduced point-of-care (POC) whole-blood EID testing in 33 health facilities and scaled up to 130 facilities in 2020. We assessed results turnaround time and ART linkage pre-POC and during POC testing. We evaluated EID register data for HEI at 10 health facilities with POC and EID testing volume of ≥ 12 infants/month from 2018 to 2021. We abstracted data for 12 months before and after POC testing rollout and compared time to sample collection, results receipt, and ART initiation between periods using medians, Wilcoxon, and log-rank tests. Data for 4.004 HEI were abstracted, of which 1.685 (42%) were from the pre-POC period and 2.319 (58%) were from the period during POC; 3.773 (94%) had a first EID test (pre-POC: 1.649 [44%]; during POC: 2.124 [56%]). Median age at sample collection was 44 (IQR 38-51) days pre-POC and 42 (IQR 33-50) days during POC (p < 0.001). Among 3.773 HEI tested, 3.678 (97%) had test results. HIV-positive infants' (n = 69) median age at sample collection was 94 (IQR 43-124) days pre-POC and 125 (IQR 74-206) days during POC (p = 0.04). HIV positivity rate was 1.6% (27/1.617) pre-POC and 2.0% (42/2.061) during POC (p = 0.43). For all infants, median days from sample collection to results receipt by infants' caregivers was 28 (IQR 14-52) pre-POC and 1 (IQR 0-25) during POC (p < 0.001); among HIV-positive infants, median days were 23 (IQR 7-30) pre-POC and 0 (0-3) during POC (p < 0.001). Pre-POC, 4% (1/23) HIV-positive infants started ART on the sample collection day compared to 33% (12/37) during POC (p < 0.001); ART linkage ≤ 7 days from HIV diagnosis was 74% (17/23) pre-POC and 95% (35/37) during POC (p < 0.001). POC testing improved EID results turnaround time and ART initiation for HIV-positive infants. While POC testing expansion could further improve ART linkage and loss to follow-up, there is need to explore barriers around same-day ART initiation for infants receiving POC testing.
Sections du résumé
BACKGROUND
BACKGROUND
Uganda Ministry of Health (MOH) recommends a first HIV DNA-PCR test at 4-6 weeks for early infant diagnosis (EID) of HIV-exposed infants (HEI) and immediate return of results. WHO recommends initiating antiretroviral therapy (ART) ≤ 7 days from HIV diagnosis. In 2019, MOH introduced point-of-care (POC) whole-blood EID testing in 33 health facilities and scaled up to 130 facilities in 2020. We assessed results turnaround time and ART linkage pre-POC and during POC testing.
METHODS
METHODS
We evaluated EID register data for HEI at 10 health facilities with POC and EID testing volume of ≥ 12 infants/month from 2018 to 2021. We abstracted data for 12 months before and after POC testing rollout and compared time to sample collection, results receipt, and ART initiation between periods using medians, Wilcoxon, and log-rank tests.
RESULTS
RESULTS
Data for 4.004 HEI were abstracted, of which 1.685 (42%) were from the pre-POC period and 2.319 (58%) were from the period during POC; 3.773 (94%) had a first EID test (pre-POC: 1.649 [44%]; during POC: 2.124 [56%]). Median age at sample collection was 44 (IQR 38-51) days pre-POC and 42 (IQR 33-50) days during POC (p < 0.001). Among 3.773 HEI tested, 3.678 (97%) had test results. HIV-positive infants' (n = 69) median age at sample collection was 94 (IQR 43-124) days pre-POC and 125 (IQR 74-206) days during POC (p = 0.04). HIV positivity rate was 1.6% (27/1.617) pre-POC and 2.0% (42/2.061) during POC (p = 0.43). For all infants, median days from sample collection to results receipt by infants' caregivers was 28 (IQR 14-52) pre-POC and 1 (IQR 0-25) during POC (p < 0.001); among HIV-positive infants, median days were 23 (IQR 7-30) pre-POC and 0 (0-3) during POC (p < 0.001). Pre-POC, 4% (1/23) HIV-positive infants started ART on the sample collection day compared to 33% (12/37) during POC (p < 0.001); ART linkage ≤ 7 days from HIV diagnosis was 74% (17/23) pre-POC and 95% (35/37) during POC (p < 0.001).
CONCLUSION
CONCLUSIONS
POC testing improved EID results turnaround time and ART initiation for HIV-positive infants. While POC testing expansion could further improve ART linkage and loss to follow-up, there is need to explore barriers around same-day ART initiation for infants receiving POC testing.
Identifiants
pubmed: 38750529
doi: 10.1186/s12981-024-00613-8
pii: 10.1186/s12981-024-00613-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
31Subventions
Organisme : President's Emergency Plan for AIDS Relief (PEPFAR) through US Centre for Disease Control and Prevention
ID : GH001353-01
Informations de copyright
© 2024. The Author(s).
Références
Joint United Nations Programme on HIV/AIDS. Start free, stay free, AIDS free: Final report on 2020 targets. Geneva; 2021
World Health Organization. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. Geneva: World Health Organization; 2021.
UNAIDS. Prevailing against pandemics by putting people at the center: World AIDS day report 2020
UNAIDS. UNAIDS Data 2020 Geneva: Joint United Nations Programme on HIV/AIDS. https://www.unaids.org/en/resources/documents/2020/unaids-data .
UNAIDS. UNAIDS Data 2022 Geneva: Joint United Nations Programme on HIV/AIDS. https://www.unaids.org/en/resources/documents/2023/2022_unaids_data .
MOH. Consolidated guidelines for prevention and treatment of HIV in Uganda. Uganda: Ministry of Health; 2016.
WHO. WHO recommendations on the diagnosis of HIV infection in infants and children. Geneva: World Health Organization; 2010.
World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017.
Ministry of Health. District health information system 2. Uganda: Ministry of Health; 2020.
Uganda AIDS Commission. Annual Joint AIDS Review Report 2020/21. Uganda; 2021.
World Health Organization. WHO Public Reports for In Vitro Diagnostics. https://extranet.who.int/prequal/vitro-diagnostics/prequalification-reports/whopr .
Jani IV, Meggi B, Loquiha O, Tobaiwa O, Mudenyanga C, Zitha A, et al. Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients. AIDS. 2018;32(11):1453–63.
doi: 10.1097/QAD.0000000000001846
pubmed: 29746301
Mwenda R, Fong Y, Magombo T, Saka E, Midiani D, Mwase C, et al. Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi. Clin Infect Dis. 2018;67(5):701–7.
doi: 10.1093/cid/ciy169
pubmed: 29490026
pmcid: 6093992
Ministry of Health. National health facility master list 2018. Kampala: Ministry of Health; 2018.
Uganda Bureau of Statistics. Uganda national household survey 2019/2020. Kampala: UBOS; 2021.
Ministry of Health. Consolidated guidelines for prevention and treatment of HIV in Uganda. Kampala: Ministry of Health; 2016.
Boeke CE, Joseph J, Wang M, Abate ZM, Atem C, Coulibaly KD, et al. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries. J Int AIDS Soc. 2021;24(3):e25677.
doi: 10.1002/jia2.25677
pubmed: 33745234
pmcid: 7981587
Bwire G, Ario AR, Eyu P, Ocom F, Wamala JF, Kusi KA, et al. The COVID-19 pandemic in the African continent. BMC Med. 2022;20(1):1–23.
doi: 10.1186/s12916-022-02367-4
Tumwesigye NM, Denis O, Kaakyo M, Biribawa C. Effects of the COVID-19 pandemic on health services and mitigation measures in Uganda. Washington: Center for Global Development Washington; 2021.
Exemplars in Global Health. Essential Health Services: Uganda. https://www.exemplars.health/emerging-topics/epidemic-preparedness-and-response/essential-health-services .
PEPFAR. Viral Load and Early Infant Diagnosis (VL/EID) Implementation Subject Matter Experts (ISMEs) Reference Manual 2019 https://aslm.org/wp-content/uploads/2019/02/VL-EID-ISME-Community-of-Practice-Reference-Manual-COP19-01172019.pdf .
Kahungu MM, Kiwanuka J, Kaharuza F, Wanyenze RK. Factors associated with HIV positive sero-status among exposed infants attending care at health facilities: a cross sectional study in rural Uganda. BMC Public Health. 2018;18(1):1–11.
doi: 10.1186/s12889-018-5024-6
Bianchi F, Cohn J, Sacks E, Bailey R, Lemaire J-F, Machekano R, et al. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries. Lancet HIV. 2019;6(6):e373–81.
doi: 10.1016/S2352-3018(19)30033-5
pubmed: 30987937
Kiyaga C, Narayan V, McConnell I, Elyanu P, Kisaakye LN, Joseph E, et al. Uganda’s “EID systems strengthening” model produces significant gains in testing, linkage, and retention of HIV-exposed and infected infants: an impact evaluation. PLoS ONE. 2021;16(2):e0246546.
doi: 10.1371/journal.pone.0246546
pubmed: 33539425
pmcid: 7861549
World Health Organization. HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: Switzerland; 2018.
Kiyaga C, Fong Y, Okiira C, Kushemererwa GE, Kayongo I, Tadeo I, et al. HIV viral load assays when used with whole blood perform well as a diagnostic assay for infants. PLoS ONE. 2022;17(6):e0268127.
doi: 10.1371/journal.pone.0268127
pubmed: 35771878
pmcid: 9246233
Dakum P, Tola M, Iboro N, Okolo CA, Anuforom O, Chime C, et al. Correlates and determinants of early infant diagnosis outcomes in north-central Nigeria. AIDS Res Ther. 2019;16:1–7.
doi: 10.1186/s12981-019-0245-z
Ponticiello M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, King R, Sundararajan R. “Everything is a mess”: how COVID-19 is impacting engagement with HIV testing services in rural Southwestern Uganda. AIDS Behav. 2020;24:3006–9.
doi: 10.1007/s10461-020-02935-w
pubmed: 32451939
pmcid: 7246959
Bell D, Hansen KS, Kiragga AN, Kambugu A, Kissa J, Mbonye AK. Predicting the impact of COVID-19 and the potential impact of the public health response on disease burden in Uganda. Am J Trop Med Hyg. 2020;103(3):1191.
doi: 10.4269/ajtmh.20-0546
pubmed: 32705975
pmcid: 7470592